期刊文献+

WT1、Bcl-2、Ki-67蛋白在上皮性卵巢癌中的表达及其相关性研究 被引量:11

The expression and ralationship of WT1,Bcl-2 and Ki-67 protein in epithelial ovarian cancer
下载PDF
导出
摘要 目的探讨上皮性卵巢癌组织中WT1、Bcl-2、Ki-67蛋白的表达及其相关性。方法采用免疫组化方法检测62例上皮性卵巢癌组织及10例正常卵巢组织中WT1、Bcl-2、Ki-67蛋白的表达情况。结果⑴10例正常卵巢组织中WT1、Ki-67蛋白均无阳性表达、Bcl-2蛋白1例阳性表达;62例上皮性卵巢癌中WT1、Bcl-2、Ki-67阳性蛋白表达率分别为80.64%(50/62)、53.23%(33/62)、82.26%(51/62)。⑵上皮性卵巢癌组织中WT1、Bcl-2、Ki-67蛋白的表达率高于正常组织(P<0.05);WT1、Ki-67蛋白阳性表达与组织学分级和临床病理分期相关(P<0.05),Bcl-2蛋白阳性表达与组织学分级和临床病理分期不相关(P>0.05)。⑶WT1蛋白表达与Bcl-2蛋白的表达正相关(r=0.463,P<0.05),WT1蛋白与Ki-67蛋白,Ki-67蛋白与Bcl-2蛋白表达之间无相关性(r=0.012、r=0.120、P>0.05)。结论 WT1、Bcl-2、Ki-67蛋白表达在上皮性卵巢癌的发生发展过程中起重要作用,WT1可能通过上调Bcl-2抑制细胞凋亡促使卵巢癌的发生。 Objective To assess the expression of WT1,Bcl-2,Ki-67 in epithelial ovarian carcinoma and to analyze the correlation of the expression level of WT1,Bcl-2 and Ki-67,protein.Methods Consecutive sections from 62 cases of ovarian cancer and 10 normal ovarian tissues were assessed immunohistochemically for expression of WT1,Bcl-2 and Ki-67 protein.Results ⑴WT1 and ki-67 proteins were not detectable in normal ovarian tissues.Positive expression of Bcl-2 protein was observed in 1(10%) of 10 normal ovarian tissues.Positive expressions of WT1,Bcl-2 and Ki-67 proteins were 80.64%(50/62),53.23%(33/62)and 82.26%(51/62) in ovarian cancer respectively.⑵The expression of WT1,Bcl-2 and Ki-67 protein in ovarian cancer was significantly higher than that in normal ovarian tissues(P〈0.05).The expressions of WT1,Bcl-2 and ki-67 protein were respectively related to histological grade and FIGO stage(P〈0.05).The expressions of Bl-2 protein was not related to histological grade and FIGO stage(P〈0.05).⑶A significantly positive relationship was observed between WT1 and Bcl-2 protein expression in primary epithelial ovarian cancer(r=0.463,P〉0.05).There was no correlation beween the expressions of WT1 and ki-67,Bcl-2 and ki-67 proteins in epithelial ovarian cancer(r=0.012、r=0.120,P〈0.05).Conclusion These results suggest that WT1 and ki-67 may be involved in the occurrence and development of ovarian cancer.WT1 by upregulating Bcl-2 inhibits apoptosis promote ovarian cancer.
出处 《江西医药》 CAS 2015年第1期16-19,共4页 Jiangxi Medical Journal
基金 江西省上饶市科技计划(20142CZD04)
关键词 卵巢肿瘤 WT1 BCL-2 KI-67 免疫组化 Ovarian neoplasms WT1 Bcl-2 ki-67 immunohistochemistry
  • 相关文献

参考文献21

  • 1Mayo MW,Wang CY,Drouin SS,et al. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 protooncogene [J]. EM- BO J, 1999,18(14) :3990-4003. 被引量:1
  • 2Viale G, Maisonneuve P, Bonoldi E, et al. The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patients[J]. Ann Onc, 1997,8(5) : 469-476. 被引量:1
  • 3Baekelandt M,Kristensen GB,Nesland JM,et al. Clinical Signifi- cance of Apoptosis-Related Factors p53,Mdm2,and Bc1-2 in Advanced Ovarian Cancer[J]. J Clin Oncol, 1999,17(7):2061. 被引量:1
  • 4Loeb DM,sukumar S. The role of WT1 in oncogenesis:tumor sup- pressor or oncogene?[J]. Int J Hematol, 2002,76(2) : 117-126. 被引量:1
  • 5Yang L,Han Y,Saiz FS,et al. A tumor suppressor and oncogene: the WT1 story[J]. Leukemia, 2007,21(5) : 868-876. 被引量:1
  • 6Liu Z, Yamanouchi K, Ohtao T, et al. High Levels of Wilms" Tumor 1 (WT1) Expression Were Associated with Aggressive Clinical Fea- tures in Ovarian Cancer [J]. Anticaneer Res,2014,34 (5):2331- 2340.". 被引量:1
  • 7Cathro HP,Stoler MH. The utility of calretinin,inhibin,and WT1 immunohistochemical staining in the differential diagnosis of ovari- an tumors[J]. Hum Pathol,2005,36(2):195-201. 被引量:1
  • 8Goldstein NS,Uzieblo A. WT1 immunoreactivity in uterine papil- lary serous carcinomas is different from ovarian serous carcinomas [J]. Am J Clin Patho1,2002,117(4):541-545. 被引量:1
  • 9Kriplani D,Patel MM. Immunohistochemistry:A diagnostic aid in differentiating primary epithelial ovarian tumors and tumors metastatic to the ovary[J]. South Asian J Cancer,2013,2(4) :254- 258. 被引量:1
  • 10Acs G,Pasha T,Zhang PJ. WT1 is differentially expressed in serous,endometrioid,clear cell,and mucinous carcinomas of the peritoneum,fallopian tube,ovary,and endometrium [J]. Int J Gy- necol Pathol, 2004,23(2) : 110-118. 被引量:1

二级参考文献6

共引文献13

同被引文献105

引证文献11

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部